calanderBy Prof. Sackscalander14 October 2020
PPAR alpha delta : what you need to know about the latest results

Prof Sacks, USA reviews the available data about PPAR alpha delta and the Elafibranor clinical program (RESOVE-IT). The interim results were presented earlier this year. They are somewhat disappointing (especially regarding the primary liver outcome).